Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Liver Transpl. 2019 Nov 4;25(12):1778–1789. doi: 10.1002/lt.25633

Table 5. Multivariate analysis for EAD in 230 patients with high MELD (MELD≥35).

Pre-LT rifaximin < 28 days and longer WIT were identified independent risk factors for EAD.

Factors Odds ratio 95% C.I. (lower-upper) p value
Pre-LT rifaximin < 28 days 2.015 1.071–3.792 0.03
WIT (min) 1.052 1.026–1.079 <0.001
Donor age (years) 1.014 0.992–1.035 0.21
Donor BMI (kg/m2) 1.027 0.968–1.090 0.377